ArticleFrontiers in immunology2025
Mepolizumab for hypereosinophilic syndrome: effectiveness and safety from real-world evidence.
Elvira Mora et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleFrontiers in immunology2025
Elvira Mora et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.